In summary, we find that synergetic suppression of miR-215-5p on PCDH9 expression is more efficient than targeting the promoter or 3′UTR alone in gliomas, and miR-215-5p promotes aggressive glioma phenotypes via inhibiting PCDH9 expression. Here, PCDH9 is linked to central nervous system cancer.